Logo for Third Harmonic Bio Inc

Third Harmonic Bio Investor Relations Material

Latest events

Logo for Third Harmonic Bio

Q1 2024

15 May, 2024
Logo for Third Harmonic Bio

Q4 2023

26 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Third Harmonic Bio Inc

Access all reports
Third Harmonic Bio Inc., operating under the ticker THRD, is a clinical-stage biopharmaceutical company dedicated to developing therapies for inflammatory diseases affecting the skin, respiratory system, and gastrointestinal tract. The company is actively working on novel treatments and focuses on KIT inhibition, a key regulatory mechanism in mast cell function, which plays a substantial role in inflammatory responses across these conditions. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.